Does inhibiting Sur1 complement rt-PA in cerebral ischemia? - Wikidata - wikimedia - TriplyDB

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

http://www.wikidata.org/entity/Q36426567

about

Sulfonylurea receptor 1 in central nervous system injury: a focused review Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema Glyburide is associated with attenuated vasogenic edema in stroke patients.Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.Glibenclamide for the treatment of ischemic and hemorrhagic stroke.Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity.Sulfonylurea receptor 1 expression in human cerebral infarcts.Glibenclamide for the treatment of acute CNS injury.Hemorrhagic transformation after ischemic stroke in animals and humans Glibenclamide in cerebral ischemia and stroke Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.Clinical predictors and management of hemorrhagic transformation.Malignant cerebral edema after large anterior circulation infarction: a review.Treatment of malignant brain edema and increased intracranial pressure after stroke.Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions.Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage.SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date

P2860

Q24606564-C8BBB1D2-B2B9-4FAC-8A7F-A29181C97251 Q26825616-D192004D-DDB7-470E-9644-89B5ADD30E56 Q30670386-64937679-DCF2-47D9-9287-9442DEE11522 Q34522397-22FFDB34-4C9F-4155-9F7C-D99415942E64 Q35380697-0DF88457-25C4-400B-BA87-641A9FD98CB8 Q35619128-1765FF0F-4857-497E-A11C-0EF87E299FFF Q36515347-0605E40A-CF2C-4854-A715-3C28FE37CE77 Q36825406-5DED8844-852A-420D-BDB0-27A6D59C2424 Q37167025-2E998CDA-022C-475E-8EA1-31671072C51B Q37279993-22E0BF7C-96D5-4BA0-B338-811A27BC94B7 Q37559355-F2D87F62-B5CC-4998-A8D8-3B4B977BBC26 Q37638478-14C973C3-CA01-4164-B8B8-EFBA8071F4E5 Q37674758-E6D45AFF-4ADF-4E5E-BC59-BAB168E9519D Q38074569-558E72E9-E716-43AD-A771-7B57F19B6CC2 Q38175890-C6D568A6-A6D3-4B69-B023-005C31795C6C Q38268315-5A953FFB-2722-4369-A9D3-2BD3074D91B6 Q38504678-BB3E8C88-3138-4761-929A-9820438831B8 Q39044188-759482F9-E707-4629-AD3A-928FE612BDBA Q55116313-31ADC4D6-B0C0-46DA-9415-6285126FD76F Q58777731-FCCC144A-FAC8-48C2-8A34-CB7EEB724232

P2860

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

http://www.wikidata.org/entity/Q36426567

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@ast

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@en

type

label

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@ast

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@en

prefLabel

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@ast

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@en

P1433

Q36426567-AA3AFA47-08ED-4445-A38B-B04DBC70EE8B

P1476

Q36426567-A44998FE-ED0A-45F6-9B73-61CDAD219C52

P2093

Q36426567-39DD4DC7-2477-4ABF-9AE3-5C5517BA4E0E

Q36426567-457A81BA-817B-4924-A880-14403AF92D48

Q36426567-5B63A543-2D46-4C9A-8874-56AEAF392160

Q36426567-6B8AD9DC-EF07-4525-9980-4C6FDC2DB11B

Q36426567-7C081234-F88C-498A-AA5B-E56BA7E70988

Q36426567-86A8048B-EBA1-486F-A3F8-57EFC23263FF

Q36426567-E83BD698-3AD5-4F0D-940B-A9F8EB6BD893

Q36426567-F722523C-F63D-46B7-A7F7-951FD7A649C3

P2860

Q36426567-020C2E2F-A639-4199-9479-0779113E47E4

Q36426567-02390F1D-AE1F-4A3A-B75E-AD531F484399

Q36426567-0490FB88-F9FF-41C2-91C8-E29E7121254C

Q36426567-07C28F2C-6478-44C2-8B36-29EC1577A33B

Q36426567-09739B36-EB1D-47A8-9ACB-774F210B4767

Q36426567-097C98EA-6D98-47AC-A686-EBCD83BD2230

Q36426567-14CC07F3-6E7B-4158-B46F-3BDAD5A67524

Q36426567-16CED7B0-F4BA-4E80-BCEC-E71A35EEBA0F

Q36426567-18B78EAD-9947-481C-B39F-366512A2ACB8

Q36426567-1A7B150D-5F98-4B3C-B5D2-895B5F0E78B2

P304

Q36426567-8A554D1D-EAE3-4F76-A9E8-C099F817810E

P31

Q36426567-5819BACD-0210-4743-AD68-F5D98A9E9595

P356

Q36426567-D894FF31-C69F-4DBA-9DBB-C19517FE2BE1

P407

Q36426567-1A8A87FF-735A-43B5-B995-87F8D1D454BF

P478

Q36426567-66BC7233-40C2-4592-B9EF-A1194E485CBE

P577

Q36426567-EFF66BA6-8B3B-406C-AAC6-0B0FBCADE579

P698

Q36426567-112586E4-6082-4F4D-A0FE-A683468430B2

P921

Q36426567-4D420B12-5DD7-46A4-8693-6955FBB9620B

P932

Q36426567-43E608D2-D348-4776-B617-9D239B3312FA

P356

J.1749-6632.2012.06705.X

P1433

Annals of the New York Academy of Sciences

P1476

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

@en

P2093

Barney J Stern

http://www.w3.org/2001/XMLSchema#string

Frank L Silver

http://www.w3.org/2001/XMLSchema#string

J Marc Simard

http://www.w3.org/2001/XMLSchema#string

Kevin N Sheth

http://www.w3.org/2001/XMLSchema#string

Mario Colucci

http://www.w3.org/2001/XMLSchema#string

Volodymyr Gerzanich

http://www.w3.org/2001/XMLSchema#string

W Taylor Kimberly

http://www.w3.org/2001/XMLSchema#string

Zhihua Geng

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs acting on SUR1 to treat CNS ischemia and trauma

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke

Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA

Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke

Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage

Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.

Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.

P304

95-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2012.06705.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

1268

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22994227

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

3507518

http://www.w3.org/2001/XMLSchema#string